This finding is, to an extent, at odds with some recent experimental work which has suggested that the nonselective inhibition of ACAT2 could be a worthwhile way to treat hypercholesterolemia in humans [110]. The gene discussed is ACAT2; the disease is familial hypercholesterolemia.